NASDAQ:LQDA Liquidia (LQDA) Stock Price, News & Analysis $11.63 +0.17 (+1.48%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$11.29▼$11.6450-Day Range$10.99▼$14.5052-Week Range$5.71▼$16.99Volume436,066 shsAverage Volume887,103 shsMarket Capitalization$888.65 millionP/E RatioN/ADividend YieldN/APrice Target$21.60 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Liquidia alerts: Email Address Liquidia MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside85.7% Upside$21.60 Price TargetShort InterestBearish15.02% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.78Based on 8 Articles This WeekInsider TradingSelling Shares$247,579 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.32) to ($0.38) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.27 out of 5 starsMedical Sector578th out of 936 stocksPharmaceutical Preparations Industry263rd out of 436 stocks 3.3 Analyst's Opinion Consensus RatingLiquidia has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 4 buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageLiquidia has only been the subject of 3 research reports in the past 90 days.Read more about Liquidia's stock forecast and price target. Previous Next 0.0 Short Interest Percentage of Shares Shorted15.02% of the outstanding shares of Liquidia have been sold short.Short Interest Ratio / Days to CoverLiquidia has a short interest ratio ("days to cover") of 13.8, which indicates bearish sentiment.Change versus previous monthShort interest in Liquidia has recently increased by 7.89%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldLiquidia does not currently pay a dividend.Dividend GrowthLiquidia does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for LQDA. Previous Next 3.2 News and Social Media Coverage News SentimentLiquidia has a news sentiment score of 0.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Liquidia this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for LQDA on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows6 people have added Liquidia to their MarketBeat watchlist in the last 30 days. This is an increase of 500% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Liquidia insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $247,579.00 in company stock.Percentage Held by Insiders31.60% of the stock of Liquidia is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions64.54% of the stock of Liquidia is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Liquidia's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Liquidia are expected to grow in the coming year, from ($1.32) to ($0.38) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Liquidia is -7.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Liquidia is -7.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLiquidia has a P/B Ratio of 15.93. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Liquidia's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Liquidia Stock (NASDAQ:LQDA)Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.Read More LQDA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LQDA Stock News HeadlinesJuly 23 at 5:04 AM | insidertrades.comLiquidia Co. (NASDAQ:LQDA) Insider Rajeev Saggar Sells 1,873 SharesJuly 16, 2024 | insidertrades.comLiquidia Co. (NASDAQ:LQDA) Insider Scott Moomaw Sells 1,528 SharesJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 23 at 1:10 AM | americanbankingnews.comBrokerages Set Liquidia Co. (NASDAQ:LQDA) PT at $21.60July 21, 2024 | americanbankingnews.comLiquidia (NASDAQ:LQDA) Earns Buy Rating from Needham & Company LLCJuly 19, 2024 | markets.businessinsider.comBuy Rating Affirmed Amid Legal Challenges and FDA Approval Prospects for Liquidia TechnologiesJuly 19, 2024 | markets.businessinsider.comExpert Outlook: Liquidia Through The Eyes Of 5 AnalystsJuly 18, 2024 | americanbankingnews.comLiquidia (NASDAQ:LQDA) Shares Gap Up to $12.44July 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 17, 2024 | americanbankingnews.comInsider Selling: Liquidia Co. (NASDAQ:LQDA) Insider Sells 1,528 Shares of StockJuly 17, 2024 | americanbankingnews.comRoger Jeffs Sells 8,053 Shares of Liquidia Co. (NASDAQ:LQDA) StockJuly 17, 2024 | americanbankingnews.comMichael Kaseta Sells 3,906 Shares of Liquidia Co. (NASDAQ:LQDA) StockJuly 16, 2024 | americanbankingnews.comLiquidia Co. (NASDAQ:LQDA) General Counsel Russell Schundler Sells 1,985 SharesJune 18, 2024 | globenewswire.comLiquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH)June 3, 2024 | investors.comLiquidia Stock Surges After Winning Patent Battle Vs. United TherapeuticsMay 29, 2024 | finance.yahoo.comLiquidia Corporation to Present at the 2024 Jefferies Global Healthcare ConferenceMay 17, 2024 | seekingalpha.comLiquidia Corp.: A Rich Catalyst Path Lies Ahead For Value UnlockingMay 15, 2024 | markets.businessinsider.comBullish Outlook for Liquidia Technologies with Buy Rating Amid Anticipated Patent Clarity and Market Growth OpportunitiesSee More Headlines Receive LQDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Liquidia and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/13/2024Today7/26/2024Next Earnings (Estimated)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryMedical Equipment Current SymbolNASDAQ:LQDA CUSIPN/A CIK1819576 Webwww.liquidia.com Phone(919) 328-4400FaxN/AEmployees50Year FoundedN/APrice Target and Rating Average Stock Price Target$21.60 High Stock Price Target$32.00 Low Stock Price Target$3.00 Potential Upside/Downside+85.7%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($1.56) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-78,500,000.00 Net Margins-674.42% Pretax Margin-674.42% Return on Equity-177.83% Return on Assets-78.50% Debt Debt-to-Equity RatioN/A Current Ratio7.66 Quick Ratio7.50 Sales & Book Value Annual Sales$17.49 million Price / Sales50.81 Cash FlowN/A Price / Cash FlowN/A Book Value$0.73 per share Price / Book15.93Miscellaneous Outstanding Shares76,410,000Free Float52,267,000Market Cap$888.65 million OptionableOptionable Beta0.32 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDr. Roger A. Jeffs Ph.D. (Age 62)CEO & Director Comp: $1.32MMr. Michael Kaseta (Age 48)COO & CFO Comp: $890.8kMr. Russell Schundler (Age 49)General Counsel & Corporate Secretary Comp: $778.49kMr. William R. Kenan Jr.Co-FounderDr. Ginger DenisonCo-FounderMs. Sarah Krepp SPHRVice President of People & CultureMr. Jason Adair (Age 52)Chief Business Officer Mr. Scott Moomaw (Age 53)Chief Commercial Officer Dr. Rajeev Saggar M.D. (Age 50)Chief Medical Officer Mr. Michael HunterSenior Vice President of Manufacturing OperationsMore ExecutivesKey CompetitorsHeron TherapeuticsNASDAQ:HRTXMannKindNASDAQ:MNKDPro-DexNASDAQ:PDEXDURECTNASDAQ:DRRXDarioHealthNASDAQ:DRIOView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpBought 32,076 shares on 7/26/2024Ownership: 0.272%McAdam LLCSold 1,457 shares on 7/24/2024Ownership: 0.016%Rajeev SaggarSold 1,873 sharesTotal: $20,846.49 ($11.13/share)DMC Group LLCBought 10,158 shares on 7/16/2024Ownership: 0.013%Roger JeffsSold 8,053 sharesTotal: $100,904.09 ($12.53/share)View All Insider TransactionsView All Institutional Transactions LQDA Stock Analysis - Frequently Asked Questions How have LQDA shares performed this year? Liquidia's stock was trading at $12.03 at the start of the year. Since then, LQDA shares have decreased by 3.3% and is now trading at $11.63. View the best growth stocks for 2024 here. How were Liquidia's earnings last quarter? Liquidia Co. (NASDAQ:LQDA) released its quarterly earnings results on Monday, May, 13th. The company reported ($0.54) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.32) by $0.22. The business had revenue of $2.97 million for the quarter, compared to the consensus estimate of $4.31 million. Liquidia had a negative trailing twelve-month return on equity of 177.83% and a negative net margin of 674.42%. When did Liquidia IPO? Liquidia (LQDA) raised $50 million in an IPO on Thursday, July 26th 2018. The company issued 4,500,000 shares at a price of $10.00-$12.00 per share. Jefferies and Cowen served as the underwriters for the IPO and Needham & Company and Wedbush PacGrow were co-managers. Who are Liquidia's major shareholders? Liquidia's top institutional shareholders include Bank of New York Mellon Corp (0.27%), Simplicity Wealth LLC (0.04%), McAdam LLC (0.02%) and Whitcomb & Hess Inc. (0.01%). Insiders that own company stock include Caligan Partners Lp, Russell Schundler, Michael Kaseta, Rajeev Saggar, Robert A Lippe, Scott Moomaw, Jason Adair and Arthur S Kirsch. View institutional ownership trends. How do I buy shares of Liquidia? Shares of LQDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Liquidia own? Based on aggregate information from My MarketBeat watchlists, some other companies that Liquidia investors own include VBI Vaccines (VBIV), OPKO Health (OPK), Aldeyra Therapeutics (ALDX), Sorrento Therapeutics (SRNE), vTv Therapeutics (VTVT), Genocea Biosciences (GNCA) and Inovio Pharmaceuticals (INO). This page (NASDAQ:LQDA) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liquidia Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Liquidia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
